NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Broken String Biosciences

Broken String Biosciences

Private
CambridgeHealthcare & Life Scienceshttps://www.brokenstringbio.com/

Last Round

Series A

Sep 18, 2023

Total Funding Raised

$19M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Broken String Biosciences is a biotechnology company that develops a sequencing platform to enhance the safety and efficacy of cell and gene therapies through advanced sequencing techniques, bioinformatics, and artificial intelligence.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

gene editingoff-target analysisgenomics researchCRISPR-Cas9next-generation sequencingNGSDNA break mappinggene therapygenomic safetybioinformaticsplatform as a servicePaaSgRNA selectionbiotech R&Dgenomic de-riskingAI-augmented biotechprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Broken String Biosciences Comparables

Compare Broken String Biosciences with similar companies based on industry and business-model similarity.

Broken String Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Countagen AB
80%
MaxCyte Inc
77%
Danaher Corporation
68%

Broken String Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 18, 2023
SeedJan 21, 2022
AcceleratorFeb 8, 2021

Key People

Founding team and executive leadership

Vincent Smith

Chief Technology Officer

Executive Team

Broken String Biosciences Investors

Notable investors and investment history

Broken String Biosciences investors
InvestorRounds
Dieter von Holtzbrinck VenturesSeries A, Seed
KorysSeries A
HERAN PartnersSeries A
Time Boost Capital I LPSeed
Merieux DevelopementSeries A
First In VenturesSeed
Mérieux Equity PartnersSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 21, 2026

    Monthly visitors increased 38% MoM.

  • Mar 31, 2026

    Launched new branding and a comprehensive website.

Broken String Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Broken String Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Broken String Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge
Employee Range37
Year Founded2020
Last FundingSep 18, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.